Home > Cashflow Statement > EMCURE PHARMACEUTICALS

EMCURE PHARMACEUTICALS
Net Cash Inflow / Outflow

    Back to Cashflow Statement
EMCURE PHARMACEUTICALS is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
AD     Remove this Ad

EMCURE PHARMACEUTICALS Last 5 Year Net Cash Inflow / Outflow History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Net Cash Inflow / Outflow ₹-56 Cr₹221 Cr₹134 Cr₹-172 Cr₹264 Cr

What is the latest Net Cash Inflow / Outflow ratio of EMCURE PHARMACEUTICALS ?

The latest Net Cash Inflow / Outflow ratio of EMCURE PHARMACEUTICALS is ₹-56 Cr based on Mar2025 Consolidated results.
Year Net Cash Inflow / Outflow
Mar2025₹-56 Cr
Mar2024₹221 Cr
Mar2023₹134 Cr
Mar2022₹-172 Cr
Mar2021₹264 Cr

How is Net Cash Inflow / Outflow of EMCURE PHARMACEUTICALS Trending?

Years Net Cash Inflow / Outflow % Change
Mar2025 ₹-56 Cr
Negative
Mar2024 ₹221 Cr
64.85
Mar2023 ₹134 Cr
Positive
Mar2022 ₹-172 Cr
Negative
Mar2021 ₹264 Cr -

Compare Net Cash Inflow / Outflow of peers of EMCURE PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
EMCURE PHARMACEUTICALS ₹27,274.9 Cr -2.2% -7.7% 44.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹413,753.0 Cr 1.5% 5.5% 0.5% Stock Analytics
DIVIS LABORATORIES ₹167,032.0 Cr 2.3% 3.6% 7.8% Stock Analytics
TORRENT PHARMACEUTICALS ₹143,426.0 Cr -0.5% 5.3% 40.2% Stock Analytics
CIPLA ₹108,360.0 Cr -1.1% -2.2% -8.9% Stock Analytics
DR REDDYS LABORATORIES ₹106,859.0 Cr 0.9% 5.2% 7% Stock Analytics


EMCURE PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
EMCURE PHARMACEUTICALS

-2.2%

-7.7%

44.4%

SENSEX

0.2%

1.1%

8.8%


You may also like the below Video Courses